Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • A study of S-241656 and a drug combination in patients with certain types of cancer involving KRAS, BRAF, or other RAS/MAPK mutations

    Recruiting

    2 1 1 1
    Denmark France Italy Spain
  • A study to evaluate the safety and effectiveness of NIO752 in patients with progressive supranuclear palsy

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium France Germany Italy The Netherlands Spain
  • A study of PF-08634404, ipilimumab, and axitinib in adults with advanced or metastatic kidney cancer

    Recruiting

    1 1 1 1
    Investigated Drugs:
    Germany Spain
  • A study of eloralintide in adults with persistent obesity or overweight who are currently treated with a weekly incretin medication

    Recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Czechia Romania Spain
  • A study comparing BGB-11417 and zanubrutinib with venetoclax and acalabrutinib for patients with previously untreated chronic lymphocytic leukemia

    Recruiting

    3 1 1 1
    Czechia France Germany Italy The Netherlands Poland +3
  • A study comparing mifamurtide to sorafenib for treating high-risk osteosarcoma in children and young adults

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Poland
  • A study to evaluate the safety and effectiveness of darizmetinib hydrochloride in patients who have had liver surgery due to colon cancer metastases

    Recruiting

    1 1
    Investigated Diseases:
    France Germany Spain
  • A study on the long-term safety and effectiveness of giroctocogene fitelparvovec or fidanacogene elaparvovec in patients with hemophilia A or hemophilia B

    Recruiting

    3 1 1
    France Germany Greece Italy Spain Sweden
  • A study to evaluate the efficacy and safety of trospium chloride and xanomeline tartrate for the treatment of schizophrenia in adolescents aged 13 to 17 years

    Recruiting

    3 1
    Romania
  • A study to evaluate the effectiveness and safety of vamifeport in adults with hereditary hemochromatosis

    Recruiting

    2 1
    Investigated Drugs:
    Austria Belgium Czechia France Germany Ireland +5